Moderator: James R. Howe, MD, FACS, Iowa City, IA
Co-Moderator: Electron Kebebew, MD, FACS, Stanford, CA

Neuroendocrine tumors arise from cells throughout the endocrine system. They comprise a broad family of tumors of which the most common are carcinoid tumors (most commonly arising from the lungs/bronchi or gastrointestinal tract) and pancreatic neuroendocrine tumors. Less common neuroendocrine tumors arise from the thymus, parathyroid, thyroid, adrenal, and pituitary glands. The appropriate diagnosis and treatment of these tumors often involves a multidisciplinary team, using specific biochemical, radiological, and surgical approaches. This session will discuss the diagnosis and management of these diverse, rare tumors, including therapeutic options for neuroendocrine liver metastases.

Presentations and Speakers

Epidemiology and Advances in Neuroendocrine Tumors
Electron Kebebew, MD, FACS, Stanford, CA

Controversies in the Management of Small Bowel Neuroendocrine Tumors (NETs)
Xavier M. Keutgen, MD, Chicago, IL

Surgical Strategies for Pancreatic NETs
James R. Howe, MD, FACS, Iowa City, IA

The Role of Medical Management of NETs
Matthew Kulke, MD, Boston, MA

The Advent of 68 Gallium Scanning and Peptide Radioreceptor Therapy for NETs in the U.S.
Heather Jacene, MD, Boston, MA